Although previous studies showed the correlation of CCL2/CCR2 with glioma recurrence and poor survival rates in preclinical27 and clinical28 settings, along with their relevance to MRI diagnostic results, no significant correlation between CCL2 expression level and MRI data have been proposed. This evidence concerns the gene CCL2 and central nervous system cancer.